To direct the Comptroller General of the United States to submit a report describing the response of certain entities to the COVID-19 pandemic with respect to the development, regulatory evaluation, and deployment of diagnostic tests.
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (May 12, 2020)
This bill requires the Government Accountability Office (GAO) to report on diagnostic tests to diagnose COVID-19 (i.e., coronavirus disease 2019) or detect the virus that causes the disease. Specifically, the report must describe the response of, among others, laboratories, diagnostic test manufacturers, and government entities with respect to the development, regulatory evaluation, and deployment of diagnostic tests. The GAO must also assess standards, guidance, clinical processes, and intergovernmental coordination related to COVID-19 testing.
What just happenedMay 12, 2020
Referred to the House Committee on Energy and Commerce.
Who’s behind it
- Introduced in HouseMay 12, 2020
- May 12, 2020IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - May 12, 2020IntroReferralIntro-H
Introduced in House
- May 12, 2020IntroReferral1000
Introduced in House